The US Food and Drug Administration has approved the use of the experimental drug aducanumab for Alzheimer’s disease. CNN looks at this drug that was developed for patients with mild cognitive impairment, not severe dementia, and is intended to slow progression of Alzheimer’s disease — not just ease symptoms.
For much of the past century, a definitive Alzheimer’s diagnosis could only be made during an autopsy. Scientific American explores how brain imaging and spinal fluid tests now make it possible to spot the disease in patients even before the initial symptoms appear.
Could brain pulses someday replace clicks of a computer mouse? Using your thoughts to make things happen in the real world was once a thing of science fiction. Now Facebook, Neurable, NextMind, and other tech firms are championing brain-controlled gadgets as the next big thing. The Washington Post weighs the pros and cons of this innovative technology.